Pàgina inicial > Resultats de la cerca: Valent, P.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
15 p, 1.6 MB The ABNL-MARRO 001 study : a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes / Moyo, Tamara K. (Vanderbilt University School of Medicine) ; Mendler, Jason H (University of Rochester Medical Center) ; Itzykson, Raphael (Paris Diderot University) ; Kishtagari, Ashwin (Vanderbilt University School of Medicine) ; Solary, Eric (Institut Gustave Roussy. Université Paris-Saclay) ; Seegmiller, Adam C. (Vanderbilt University School of Medicine) ; Gerds, Aaron T. (Cleveland Clinic) ; Ayers, Gregory D. (Vanderbilt University School of Medicine) ; Dezern, Amy E. (Johns Hopkins University) ; Nazha, Aziz (Cleveland Clinic) ; Valent, Peter (Ludwig Boltzmann Institute for Hematology and Oncology. Medical University of Vienna) ; Onida, Francesco (University of Milan) ; Van Azizan de Loosdrecht, Arjan A. (Amsterdam UMC. University Medical Center) ; Pleyer, Lisa (Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials) ; Xicoy Cirici, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tibes, Raoul (Mayo Clinic) ; Geissler, Klaus (Sigmund Freud University) ; Komrokji, Rami S. (H. Lee Moffitt Cancer Center) ; Zhang, Jing (University of Wisconsin-Madison) ; Germing, Ulrich (Department of Hematology. Oncology. and Clinical Immunology. University of Duesseldorf) ; Steensma, David P. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Wiseman, Daniel H. (University of Manchester) ; Pfeilstöecker, Michael (Hanusch Hospital and Ludwig Boltzmann Institute for Hematology and Oncology) ; Elena, Chiara (University of Pavia) ; Cross, Nicholas C P (University of Southampton) ; Luebbert, Michael (University of Freiburg) ; Mesa, Ruben A. (Mays Cancer Center at UT Health San Antonio MD Anderson) ; Montalban-Bravo, Guillermo (MD Anderson Cancer Center) ; Sanz, G.F. (Hospital Universitari i Politècnic La Fe (València)) ; Platzbecker, Uwe (University Hospital Leipzig) ; Patnaik, Mrinal M. (Mayo Clinic) ; Padron, Eric (H. Lee Moffitt Cancer Center) ; Santini, Valeria (University of Florence) ; Fenaux, Pierre (Paris Diderot University) ; Savona, Michael R. (Vanderbilt University School of Medicine) ; Universitat Autònoma de Barcelona
Background: Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) comprise several rare hematologic malignancies with shared concomitant dysplastic and proliferative clinicopathologic features of bone marrow failure and propensity of acute leukemic transformation, and have significant impact on patient quality of life. [...]
2022 - 10.1186/s12885-022-10073-w
BMC Cancer, Vol. 22 Núm. 1 (december 2022) , p. 1013  
Registre complet - Creative Commons
2.
15 p, 3.4 MB Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS / Kuendgen, A. (University Hospital Duesseldorf) ; Nomdedeu, Meritxell (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tuechler, H. (Boltzmann Institute for Leukemia Research. Hanusch Hospital) ; Garcia-Manero, Guillermo (MD Anderson Cancer Center) ; Komrokji, R. S. (H Lee Moffitt Cancer Center) ; Sekeres, M. A. (Taussig Cancer Institute. Cleveland Clinic) ; Della Porta, M. G. (Humanitas Research Hospital (Itàlia)) ; Cazzola, Mario (IRCCS Policlinico San Matteo Foundation) ; DeZern, A. E. (Johns Hopkins University. Sidney Kimmel Comprehensive Cancer Center) ; Roboz, G. J. (Weill Cornell Medicine and The New York Presbyterian Hospital) ; Steensma, D. P. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Van de Loosdrecht, A. A. (Vrije Universiteit Amsterdam) ; Schlenk, R. F. (Heidelberg University Hospital (Alemanya)) ; Grau, J. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Calvo, Xavier (Institut Hospital del Mar d'Investigacions Mèdiques) ; Blum, S. (Lausanne University Hospital) ; Pereira, A. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Valent, P. (Medical University of Vienna) ; Costa, D. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Giagounidis, A. (Marienhospital Duesseldorf) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Döhner, H. (University Hospital of Ulm (Alemanya)) ; Platzbecker, Uwe (University Hospital Leipzig) ; Pedro, Carme (Hospital del Mar (Barcelona, Catalunya)) ; Lübbert, M. (University Medical Center Freiburg) ; Oiartzabal, I. (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ; Díez-Campelo, M. (Hospital Universitario de Salamanca) ; Cedena, María Teresa (Hospital Universitario 12 de Octubre (Madrid)) ; Machherndl-Spandl, S. (St Vincent's Hospital (Sydney)) ; López-Pavía, M. (Hospital General Universitario de Valencia) ; Baldus, C. D. (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; Martinez-de-Sola, M. (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Stauder, R. (Innsbruck Medical University) ; Merchan, B. (Hospital Universitari Vall d'Hebron) ; List, A. (H Lee Moffitt Cancer Center) ; Ganster, Christina (University Medical Center Göttingen) ; Schroeder, T. (University Hospital Duesseldorf) ; Voso, Maria Teresa (Tor Vergata University. Department of Biomedicine and Prevention) ; Pfeilstöcker, M. (Hanusch Krankenhaus Wien) ; Sill, H. (Medizinische Universität Graz) ; Hildebrandt, B. (University Duesseldorf. Institute of Human Genetics) ; Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ; Nomdedeu, B. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cobo, Fernando (Hospital Quirón Teknon) ; Haas, R. (University Hospital Duesseldorf) ; Sole, F. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Germing, U. (University Hospital Duesseldorf) ; Greenberg, P. L. (Stanford University Cancer Center) ; Haase, Detlef (University Medical Center Göttingen) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Universitat Autònoma de Barcelona
In the current World Health Organization (WHO)-classification, therapy-related myelodysplastic syndromes (t-MDS) are categorized together with therapy-related acute myeloid leukemia (AML) and t-myelodysplastic/myeloproliferative neoplasms into one subgroup independent of morphologic or prognostic features. [...]
2020 - 10.1038/s41375-020-0917-7
Leukemia, 2020  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Valent, Peter
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem